- Home
- BLCO vs NBIS Comparison
BLCO vs NBIS Comparison
Compare BLCO & NBIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLCO
- NBIS
- Stock Information
- Founded
- BLCO 1853
- NBIS 2000
- Country
- BLCO Canada
- NBIS Netherlands
- Employees
- BLCO N/A
- NBIS N/A
- Industry
- BLCO Ophthalmic Goods
- NBIS
- Sector
- BLCO Health Care
- NBIS
- Exchange
- BLCO Nasdaq
- NBIS NYSE
- Market Cap
- BLCO 4.9B
- NBIS 4.8B
- IPO Year
- BLCO 2022
- NBIS 2011
- Fundamental
- Price
- BLCO $13.72
- NBIS $53.53
- Analyst Decision
- BLCO Hold
- NBIS Strong Buy
- Analyst Count
- BLCO 13
- NBIS 4
- Target Price
- BLCO $15.83
- NBIS $62.50
- AVG Volume (30 Days)
- BLCO 758.1K
- NBIS 12.2M
- Earning Date
- BLCO 07-30-2025
- NBIS 07-30-2025
- Dividend Yield
- BLCO N/A
- NBIS N/A
- EPS Growth
- BLCO N/A
- NBIS N/A
- EPS
- BLCO N/A
- NBIS N/A
- Revenue
- BLCO $4,829,000,000.00
- NBIS $161,400,000.00
- Revenue This Year
- BLCO $6.97
- NBIS $38,351.91
- Revenue Next Year
- BLCO $5.48
- NBIS $134.64
- P/E Ratio
- BLCO N/A
- NBIS N/A
- Revenue Growth
- BLCO 11.94
- NBIS N/A
- 52 Week Low
- BLCO $10.45
- NBIS $14.09
- 52 Week High
- BLCO $21.69
- NBIS $55.75
- Technical
- Relative Strength Index (RSI)
- BLCO 63.37
- NBIS N/A
- Support Level
- BLCO $12.02
- NBIS N/A
- Resistance Level
- BLCO $14.35
- NBIS N/A
- Average True Range (ATR)
- BLCO 0.45
- NBIS 0.00
- MACD
- BLCO 0.06
- NBIS 0.00
- Stochastic Oscillator
- BLCO 72.96
- NBIS 0.00
About BLCO Bausch + Lomb Corporation
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
About NBIS NEBIUS GROUP N V
Nebius Group NV is a tech company. It is a European provider of infrastructure and services to AI builders globally. The group builds full-stack infrastructure to service the growth of the AI industry, including the scale of GPU clusters, cloud platforms, tools, and services for developers. It has R&D hubs across Europe, North America and Israel.